Binding characteristics of [3H]Δ5-androstene- 3β,17β-diol to a nuclear protein in the rabbit vagina

Steroids

Volumn 69, Issue 1, 2004, Pages 71-78

  Traish, Abdulmaged M ^a   Huang, Yue Hua ^a   Min, Kweonsik ^b   Kim, Noel N ^a   Munarriz, Ricardo ^a   Goldstein, Irwin ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Inje University College of Medicine   (South Korea)

Author keywords

Androgen receptor; Estrogen receptor; Female genital arousal; Hormones; Vagina

Indexed keywords

ANDROGEN RECEPTOR; ANDROSTANOLONE; ANDROSTENEDIOL; ANDROSTENEDIOL BINDING PROTEIN; BINDING PROTEIN; ESTRADIOL; ESTROGEN RECEPTOR; NUCLEAR PROTEIN; POTASSIUM CHLORIDE; PRASTERONE; PROGESTERONE; TESTOSTERONE; TISSUE EXTRACT; TRIAMCINOLONE ACETONIDE; UNCLASSIFIED DRUG; ANDROSTANE DERIVATIVE; ANDROSTANEDIOL;

ANIMAL TISSUE; ARTICLE; BINDING KINETICS; CONTROLLED STUDY; DRUG EFFECT; DRUG PROTEIN BINDING; DRUG RECEPTOR BINDING; FEMALE; HORMONE DETERMINATION; HORMONE PROTEIN COMPLEX; HORMONE RECEPTOR INTERACTION; MACROMOLECULE; NONHUMAN; OVARIECTOMY; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; TEMPERATURE DEPENDENCE; VAGINA; ANIMAL; BINDING COMPETITION; CHEMISTRY; CYTOSOL; METABOLISM; PROTEIN BINDING; RABBIT;

ANIMALIA; ORYCTOLAGUS CUNICULUS;

ANDROSTANE-3,17-DIOL; ANDROSTENOLS; ANIMALS; BINDING, COMPETITIVE; CYTOSOL; FEMALE; NUCLEAR PROTEINS; OVARIECTOMY; PROTEIN BINDING; RABBITS; RECEPTORS, ANDROGEN; RECEPTORS, ESTROGEN; VAGINA;

EID: 0346098083     PISSN: 0039128X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.steroids.2003.10.006     Document Type: Article

References (27)

1. Huggins C., Jensen E.V., Cleveland A.S. Chemical structure of steroids in relation to promotion of growth of the vagina and uterus of the hypophysectomized rat. J. Exp. Med. 100:1954;225-243.
2. Shao T.C., Castaneda E., Rosenfield R.L., Liao S. Selective retention and formation of a delta5-androstenediol-receptor complex in cell nuclei of the rat vagina. J. Biol. Chem. 250:1975;3095-3100.
3. van Doorn L.G., Poortman J., Thijssen J.H., Schwarz F. Actions and interactions of delta 5-androstene-3 beta, 17 beta-diol and 17 beta-estradiol in the immature rat uterus. Endocrinology. 108:1981;1587-1593.
4. Van Doorn L.G., Berenschot-Roozendaal J., Poortman J., Thijssen J.H., Schwarz F. Binding characteristics of 5-androstene-3 beta, 17 beta-diol and estradiol-17 beta to the cytoplasmic estrogen receptor of the immature rat uterus. J. Steroid Biochem. 16:1982;661-671.
5. Maggiolini M., Donze O., Jeannin E., Ando S., Picard D. Adrenal androgens stimulate the proliferation of breast cancer cells as direct activators of estrogen receptor alpha. Cancer Res. 59:1999;4864-4869.
6. Markiewicz L., Gurpide E. C19 adrenal steroids enhance prostaglandin F2 alpha output by human endometrium in vitro. Am. J. Obstet. Gynecol. 159:1988;500-504.
7. Adams J.B., Seymour-Munn K. Estrogen receptor and C19-5-ene-steroid concentrations in the nuclear fraction from human breast carcinoma tissue. J. Steroid Biochem. Mol. Biol. 43:1992;499-505.
8. Seymour-Munn K., Adams J. Estrogenic effects of 5-androstene-3 beta, 17 beta-diol at physiological concentrations and its possible implication in the etiology of breast cancer. Endocrinology. 112:1983;486-491.
9. Adams J., Garcia M., Rochefort H. Estrogenic effects of physiological concentrations of 5-androstene-3 beta, 17 beta-diol and its metabolism in MCF7 human breast cancer cells. Cancer Res. 41:1981;4720-4726.
10. Adams J.B., Archibald L., Seymour-Munn K. Dehydroepiandrosterone and androst-5-ene-3 beta, 17 beta-diol in human mammary cancer cytosolic and nuclear compartments and their relationship to estrogen receptor. Cancer Res. 40:1980;3815-3820.
11. Hackenberg R., Turgetto I., Filmer A., Schulz K.D. Estrogen and androgen receptor mediated stimulation and inhibition of proliferation by androst-5-ene-3 beta, 17 beta-diol in human mammary cancer cells. J. Steroid Biochem. Mol. Biol. 46:1993;597-603.
12. Simard J., Vincent A., Duchesne R., Labrie F. Full oestrogenic activity of C19-delta 5 adrenal steroids in rat pituitary lactotrophs and somatotrophs. Mol. Cell Endocrinol. 55:1988;233-242.
13. Simard J., Labrie F. Adrenal C19-5-ene steroids induce full estrogenic responses in rat pituitary gonadotrophs. J. Steroid Biochem. 26:1987;539-546.
14. Miyamoto H., Yeh S., Lardy H., Messing E., Chang C. Delta5- androstenediol is a natural hormone with androgenic activity in human prostate cancer cells. Proc. Natl. Acad. Sci. U.S.A. 95:1998;11083-11088.
15. Chang H.C., Miyamoto H., Marwah P., Lardy H., Yeh S., Huang K.E.et al. Suppression of delta(5)-androstenediol-induced androgen receptor transactivation by selective steroids in human prostate cancer cells. Proc. Natl. Acad. Sci. U.S.A. 96:1999;11173-11177.
16. Hackenberg R., Schulz K.D. Androgen receptor mediated growth control of breast cancer and endometrial cancer modulated by antiandrogen- and androgen-like steroids. J. Steroid Biochem. Mol. Biol. 56:1996;113-117.
17. Traish A.M., Muller R.E., Wotiz H.H. Binding of 7 alpha, 17 alpha-dimethyl-19-northesterone (mibolerone) to androgen and progesterone receptors in human and animal tissues. Endocrinology. 118:1986;1327-1333.
18. Traish A.M., Muller R.E., Wotiz H.H. A new procedure for the quantitation of nuclear and cytoplasmic androgen receptors. J. Biol. Chem. 256:1981;12028-12033.
19. Katzenellenbogen J.A., Johnson H.J. Jr., Carlson K.E. Studies on the uterine, cytoplasmic estrogen binding protein. Thermal stability and ligand dissociation rate. An assay of empty and filled sites by exchange. Biochemistry. 12:1973;4092-4099.
20. Traish AM, Kim NN, Huang Y-H, Min K, Munarriz R, Goldstein I. Sex steroid hormones differentially regulate nitric oxide synthase and arginase activities in the proximal and distal rabbit vagina. Int J Impot Res, in press.
21. Labrie F., Luu-The V., Lin S.X., Simard J., Labrie C., El-Alfy M.et al. Intracrinology: role of the family of 17β-hydroxysteroid dehydrogenases in human physiology and disease. J. Mol. Endocrinol. 25:2000;1-16.
22. Begin D., Luthy I.A., Labrie F. Adrenal precursor C19 steroids are potent stimulators of growth of androgen-sensitive mouse mammary carcinoma Shionogi cells in vitro. Mol. Cell Endocrinol. 58:1988;213-219.
23. Dorfman RI, Shipley RA. Androgens: biochemistry, physiology and clinical significance. New York: Wiley; 1956. p. 152-217.
24. Whitnall M.H., Wilhelmsen C.L., McKinney L., Miner V., Seed T.M., Jackson W.E. III Radioprotective efficacy and acute toxicity of 5-androstenediol after subcutaneous or oral administration in mice. Immunopharmacol. Immunotoxicol. 24:2002;595-626.
25. Whitnall M.H., Elliott T.B., Landauer M.R., Wilhelmsen C.L., McKinney L., Kumar K.S.et al. Protection against gamma-irradiation with 5-androstenediol. Mil. Med. 167(Suppl. 2):2002;64-65.
26. Whitnall M.H., Elliott T.B., Landauer M.R., Jackson W.E. III, Wilhelmsen C.L., Mckinney L.et al. In vivo protection against gamma-irradiation with 5-androstenediol. Exp. Biol. Med. 226:2001;625-627.
27. Whitnall M.H., Elliott T.B., Harding R.A., Inal C.E., Landauer M.R., Wilhelmsen C.L.et al. Androstenediol stimulates myelopoiesis and enhances resistance to infection in gamma-irradiated mice. Int. J. Immunopharmacol. 22:2000;1-14.